Results 91 to 100 of about 831 (147)

Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density. [PDF]

Osteoporos Int
Beekman MJ, Terra L, Stuursma A, Heemskerk-Gerritsen BAM, van Lennep JER, van Beurden M, van Doorn LC, de Hullu JA, van Dorst EBL, Mom CH, Slangen BFM, Mitea C, Slart RHJA, Snoeren MM, Stokkel MP, Verberne HJ, de Keizer B, Korse CM, Gaarenstroom KN, van Engelen K, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, Berger LPV, Garcia EBG, van Asperen CJ, Hooning MJ, Maas AHEM, Mourits MJE, van Leeuwen FE, Zillikens MC.   +31 more
europepmc   +1 more source

Implementation of risk-reducing surgery for HBOC under public insurance in Japan: a single-center experience. [PDF]

Fam Cancer
Terui-Kohbata H, Takahashi S, Takamine E, Komine M, Gau M, Egawa M, Ebana Y, Aruga T, Wakana K, Yoshida M.   +9 more
europepmc   +1 more source

Retrospective Analysis of the Uptake and Timing of Risk-Reducing Salpingo-Oophorectomy in Women With BRCA1/2 Pathogenic Variants. [PDF]

Cureus
Hasegawa Y, Miura S, Nagata K, Komatsu N, Nagata A, Matsumoto M, Matsumoto K, Miura K.   +7 more
europepmc   +1 more source

Risk-Reducing Mastectomy in <i>BRCA1/2</i> and Other High-Risk Gene Carriers: Current Evidence and Practical Guidance. [PDF]

J Breast Cancer
Lee JH, Ryu JM, Park JS, Kim JH, Cha CD, Eoh KJ, Yang Y, Lee BY, Han SA, Kim SW.   +9 more
europepmc   +1 more source

Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2. [PDF]

Cancer Epidemiol Biomarkers Prev
Loehrer EA, van der Baan FH, Mooij TM, Andrieu N, Antoniou AC, Dorrius MD, Easton DF, Engel C, Kast K, Mann RM, Noguès C, Schmutzler RK, Tan YY, Eriksson M, van Gils CH, Hooning MJ, Rookus MA, Schmidt MK.   +17 more
europepmc   +1 more source

Meta-analysis of changes in epithelial ovarian cancer incidence rates associated with salpingectomy: A comparison of 2022-2023 and earlier periods. [PDF]

J Turk Ger Gynecol Assoc
Marchand G, Gonzalez Herrera D, Hamilton B, Robinson M, Kline E, Mera S, Koshaba M, Jephson G, Pulicherla N, Azadi A.   +9 more
europepmc   +1 more source

Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer. [PDF]

JAMA Netw Open
Sia J, Lane EF, Fierheller CT, Oxley S, Kalra A, Sideris M, Wei X, Mansour L, Idahl A, Fraser H, Ganesan S, Deshmukh P, Ganesan R, Hanson H, Saridogan E, Hamed H, McCluggage WG, Legood R, Sasieni P, Evans DG, Menon U, Brentnall A, Manchanda R, PROTECTOR team.   +23 more
europepmc   +1 more source

Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors. [PDF]

J Cancer Res Clin Oncol
Jörg I, Chronas D.
europepmc   +1 more source

Clinical and Pathological Characteristics and Treatment Implications of <i>BRCA1</i>- and <i>BRCA2</i>-Mutated Breast Cancer in Japanese Patients: A Single-Institution Retrospective Study. [PDF]

Breast Cancer (Auckl)
Akita Y, Iwase M, Kikumori T, Takeuchi D, Takano Y, Ichikawa T, Masuda N.   +6 more
europepmc   +1 more source

Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction. [PDF]

Isr J Health Policy Res
Michaelson-Cohen R, Armon S, Srebnik N, Volkow EK, Mor P, Gekhtman D, Rosengarten O, Lotan AM, Goldvaser H, Miller Y, Feldman DM, Molho RB, Levy MS, Kedar I, Goldberg Y, Raz Y, Simchoni S, Hoffman A, Linial M, Carmon E, Gatot I, Braha M, Shtoyerman RC, Mordechai S, Half EE, Katz L, Levi Z, Morag SB, Allweis TM, Friedman E, Levy-Lahad E, Lieberman S.   +31 more
europepmc   +1 more source